Source
Accessing clinical trial information via two social media platforms: the new normal for patients and stakeholders PRIMARY_TEXT retrieval pending
Retrieval by Galedra
BLOCKED at 2026-09-29T01:21:02Z · https://idp.nature.com/authorize?response_type=cookie&client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41598-026-71633-9 · seq 18311
Claims from this source
No claims have been extracted from this source yet.
Locations
| Locator | Excerpt |
|---|---|
QUOTE {} | Two datasets were analysed: Bluesky posts (January–May 2025, n = 8849) and Twitter (X) posts (June 25–30, 2025, n = 5520). Due to differences in data accessibility across platforms, the datasets are not temporally equivalent and are inte... |
QUOTE {} | The analysis indicates that Bluesky discourse was more cohesive and research-oriented, with a relatively more specialised vocabulary. In contrast, Twitter (X) exhibited more fragmented and event-driven communication patterns, along with ... |